06. August 2018
The Glatt pharma logistic center has now established a cold chain logistics organization and infrastructure which is state-of-the-art and which exactly addresses the costumer’s needs. Temperature ranges Each temperature range is covered: Cool (2–8°C) Frozen (-25°C) Deep frozen (-80°C) The frozen and deep frozen area is flexiblyscalable. In case costumers are looking for room, area and requiredinfrastructure to be equipped with an additional battery of refrigerators and freezers, Glatt...
09. April 2018
Video with some great insights into the last edition of DDF Summit, March 12-14, 2018 in Berlin. Good mix of innovation of drug delivery and hot topics in the pharmaceutical industry during the presentation sessions and active exchange between exhibitors and participants during the breaks. Also members of Glatt Pharmaceutical Services, the CDMO services provider for the development of complex solid dosage forms and newly also with logistic services for clinical trials and market product enjoyed...
15. March 2018
presented by Glatt @ 11th Worldmeeting on on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology -19 March to 22 March 2018 Granada, Spain On the Glatt Booth N° 3 we will exhibit our smallest continuous granulation line and inform about our solutions in micropellets, taste masking, pediatric formulation, drug delivery, etc. From our Pharmaceutical Development origin the following poster contributions: Influence of polymer content on droplet size distributions in atomized spraying...
02. October 2017
Experienced CDMO partner for solid dosage forms - Innovative solutions for multiparticulates, pellets and micro pellets
Pediatric formulation - Quality by Design and Scale up concepts - Clinical trial and commercial bulk manufacturing - Controlled substances / organic solvents handling- GMP / FDA sites in Binzen/Germany and Ramsey/USA
11. July 2017
Die Renaissance der Pellets treibt innovative Technologien voran. Formulierungen, die auf Pellets basieren, liegen in den letzten Jahren im Trend. Neue Technologien ermöglichen es, Schutzrechte an Wirkstoffen zu umgehen und stehen bei den Pharmakunden deshalb hoch im Kurs. Welches sind die wichtigsten Verfahren?